Glanbia Performance Nutrition (India) Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 16-07-2024
- Paid Up Capital ₹ 2.93 Cr
as on 16-07-2024
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 29.36%
(FY 2023)
- Profit 52.25%
(FY 2023)
- Ebitda 46.67%
(FY 2023)
- Net Worth 97.36%
(FY 2023)
- Total Assets -1.61%
(FY 2023)
About Glanbia Performance Nutrition (India)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 2.93 Cr, as per Ministry of Corporate Affairs (MCA) records.
Satyavrat Pendharkar, Gyanesh Srivastava, and Timothy Lohan serve as directors at the Company.
- CIN/LLPIN
U15132DL2014FTC269023
- Company No.
269023
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
18 Jul 2014
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Glanbia Performance Nutrition (India)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satyavrat Pendharkar  | Director | 05-Oct-2020 | Current |
| Gyanesh Srivastava | Director | 29-Oct-2020 | Current |
Timothy Lohan  | Director | 07-Feb-2022 | Current |
Financial Performance and Corporate Structure Insights of Glanbia Performance Nutrition (India).
Glanbia Performance Nutrition (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 29.36% increase. The company also saw a substantial improvement in profitability, with a 52.25% increase in profit. The company's net worth Soared by an impressive increase of 97.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Glanbia Performance Nutrition (India)?
In 2023, Glanbia Performance Nutrition (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Glanbia Performance Nutrition (India)?
Glanbia Performance Nutrition (India) has a workforce of 34 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Glanbia Performance Nutrition (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glanbia Performance Nutrition (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
